Digital Biomanufacturing Market
With a forecasted market value of $50.89 billion by 2031 and a 13.3% CAGR from 2024-2031, the Digital Biomanufacturing sector is on the rise.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
What Factors Are Driving the Growth of the Digital Biomanufacturing Market to $50.89 Billion by 2031?
Digital Biomanufacturing Market 2024-2031 According to a recent report by Meticulous Research , the global digital biomanufacturing market is set to reach $50.89 billion by 2031, growing at a compound annual growth rate (CAGR) of 13.3% from 2024 to 2031. This growth is driven by factors including the rising demand for biologics, capacity expansions of biopharmaceutical plants, and the need for process optimization. Additionally, there is an increasing emphasis on quality standards and regulatory compliance, a strong R&D pipeline for biopharmaceuticals, and a shift towards continuous bioprocessing. However, challenges such as the high costs associated with technology deployment, and the complexity of developing and manufacturing biopharmaceuticals, pose significant barriers to growth. Request for Sample Market: https://www.meticulousresearch.com/request-sample- report/cp_id=5971 The advent of Industry 4.0, advanced data analysis tools, and the transition to bioprocessing 4.0 are expected to provide substantial growth opportunities. On the other hand, issues related to process analytical technology (PAT), downstream process implementation, and the high capital requirements for biopharmaceutical production remain major challenges. Key Players: Notable companies in the digital biomanufacturing sector include GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (Germany), Cytiva (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric Co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing (U.S.), Schneider Electric SE (France), Dassault Systems (France), Oracle Corporation (U.S.), and 3M (U.S.). Market Segmentation and Outlook: The digital biomanufacturing market is segmented into several categories including offerings (software and hardware), functionalities (product design, process optimization & analytics, automation & control), bioprocesses (upstream and downstream), applications (monoclonal antibodies, recombinant hormones/proteins, vaccines, cellular-based biologics, gene-based biologics), and end-users (biopharmaceutical companies, academic and research institutes, CDMOs & CROs). In 2024, the software segment is anticipated to dominate the market, accounting for 74.4% of the share due to its crucial role in process optimization and real-time monitoring. Process optimization & analytics are expected to be the leading functionality, driven by benefits such as enhanced sustainability and reduced costs. Among bioprocesses, downstream bioprocessing will hold the largest share due to its impact on product quality and purity. In terms of applications, monoclonal antibodies will capture the largest market share of 48.6% in 2024, fueled by advancements in manufacturing technologies and rising cancer Page 1 of 2 Meticulous Research| sales@meticulousresearch.com
Digital Biomanufacturing Market 2024-2031 prevalence. Biopharmaceutical companies are projected to be the largest end-users, leveraging digital biomanufacturing for improved efficiency and regulatory compliance. Geographic Insights: The report highlights Asia-Pacific as the region with the highest growth potential, projecting a CAGR of 15.1%. The region's growth is attributed to a burgeoning pharmaceutical market, increased R&D spending, and supportive regulatory frameworks. China, in particular, is expanding its biopharmaceutical sector significantly, contributing to the market's expansion in Asia-Pacific. Buy Now: https://www.meticulousresearch.com/Checkout/62700362 About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 2 Meticulous Research| sales@meticulousresearch.com
